ArticleTheranostics2018

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.

Rebecca W Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.